Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Phase 1 study to describe pharmacokinetics of CP-690,550 in pediatric patients 2 to less than
18 years of age with Juvenile Idiopathic Rheumatoid Arthritis (JIA).